This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Sep;129(3):1138-9.

doi: 10.1053/j.gastro.2005.07.047.

Anti-tumor necrosis factor therapy for ulcerative colitis

Jannis Kountouras, Christos Zavos, Dimitrios Chatzopoulos

PMID: 16143158
DOI: 10.1053/j.gastro.2005.07.047

Comment

Anti-tumor necrosis factor therapy for ulcerative colitis

Jannis Kountouras et al. Gastroenterology. 2005 Sep.

. 2005 Sep;129(3):1138-9.

doi: 10.1053/j.gastro.2005.07.047.

Authors

Jannis Kountouras, Christos Zavos, Dimitrios Chatzopoulos

PMID: 16143158
DOI: 10.1053/j.gastro.2005.07.047

No abstract available

PubMed Disclaimer

Comment on

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.
Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B. Järnerot G, et al. Gastroenterology. 2005 Jun;128(7):1805-11. doi: 10.1053/j.gastro.2005.03.003. Gastroenterology. 2005. PMID: 15940615 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information